Reports
Reports
Sale
The global airway management devices market was estimated to be worth USD 2.6 billion in 2022. The market is likely to grow at an CAGR of 6.20% in the forecast period of 2023-2031. Driven by the growing demand for emergency and intensive care, the market is anticipated to be worth USD 4.5 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Airway management devices are the devices used for the management of airway obstruction. Airway obstruction can be acute or chronic, depending on the severity of the disease. These devices consist of set procedures and operations, which are used to prevent and treat airway obstruction.
The airway devices open the blocked pathways and provide a large area for gas exchange between the patient’s pulmonary system and the outer environment. Airway blockage is caused due to the entry of foreign objects and the accumulation of foreign fluids, like gastric and body contents. Airway management is a process done to restore normal ventilation and is essential in emergency medicine.
The most prominent devices in the market are endotracheal, oropharyngeal, and nasopharyngeal systems. The oropharyngeal systems open the pathway through the mouth, while in nasopharyngeal devices, a tube is passed through a nasal passage to open the obstructed course. In the endotracheal airways, a tube is passed through the trachea, which is further connected to the ventilator, which delivers oxygen to the lungs.
Basic and advanced airway management is done to manage regular choking to chronic blockage. Basic airway management systems are non-invasive and do not require any specialised medical equipment. On the other hand, advanced airway management systems are invasive and require suitable therapeutic interventions to manage critically ill patients.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Device Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rising prevalence of respiratory disorders, triggered by the rising pollution levels and unhealthy lifestyle habits like smoking and vaping, is aiding the demand for airway management devices market. Around 65 million cases are diagnosed with chronic obstructive pulmonary disorder, which is responsible for further propelling the growth of this market.
The increased investments in the research and development sector by top companies are also anticipated to boost the airway management devices market. The rising funds by the government authorities are expected to propel market growth.
Moreover, novel product launches will help in the expansion of the market. This is expected to generate significant revenue. For example, launching an augmented infant resuscitator will help in decreasing neonatal mortality caused due to obstructive flow.
Rapid increase in mergers and acquisitions is expected to boost the market value, as these collaborations help in the generating more significant revenue shares. For example, in 2017, MedisizeB.V. was acquired by Flexicare to expand its business in European countries. Hence, these acquisitions will help in the development of the airway management devices market during the forecast period.
Airway management devices perform therapeutic interventions for a wide range of indications. The airway management systems help treat acute blockage to chronic obstructions. The blockage is due to the inflammation of the airway, injury of the airway, and increased secretions of saliva and mucus.
The severity of the obstruction decides the treatment pathway. There are two fundamental pathways, basic and advanced. Basic airway management techniques are non-invasive and manage airway obstruction without the need for any medical equipment. The primary management techniques include abdominal thrusts and chest compressions.
The technological advancements in supraglottic airway devices are used to provide optimal oxygenation. For achieving the intubation, stylets are used for opening the obstructive airflow. In modern times, incorporating fibre optic display will give a good view of tracheal anatomy.
Laryngoscopes have witnessed rapid development in the last decade. However, the novel laryngoscopes are still under evaluation. These novel and effective devices are incorporated with optical and LED light sources that will help in the better diagnosis of pulmonary disorders.
The laryngeal masks used for intubation have also been modified with video elements to get a better and more detailed view of the chronic obstructions. The clinical trials for a laryngeal mask equipped with a disposable video camera have been completed, but it still requires further evaluation before being launched in the airway management devices market.
Scientists have also invented novel surgical interventions to treat air obstruction in chronic pulmonary disorders. In these new surgical procedures, tracheal access is assured by sensation with a finger. After confirmation, bougie and insertion of the endotracheal tube are done. Several ongoing clinical trials are emerging as they key trends which are likely to bolster the growth of the market.
The report gives an in-depth analysis of the key players involved in the airway management devices market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period |
2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Airway Management Devices Market Overview
3.1 Global Airway Management Devices Market Historical Value (2016-2022)
3.2 Global Airway Management Devices Market Forecast Value (2023-2031)
4 Global Airway Management Devices Market Landscape
4.1 Global Airway Management Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Airway Management Devices Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Airway Management Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Airway Management Devices Market Segmentation
6.1 Global Airway Management Devices Market by Type
6.1.1 Market Overview
6.1.2 Infraglottic Airway Management Devices
6.1.2.1 Endotracheal Tubes
6.1.2.2 Tracheostomy Tubes
6.1.3 Supraglottic Airway Management Devices
6.1.3.1 Laryngeal Mask Airways
6.1.3.2 Oropharyngeal Mask Airways
6.1.3.3 Nasopharyngeal Mask Airways
6.1.3.4 Others
6.1.4 Laryngoscopes
6.1.5 Resuscitators
6.1.6 Others
6.2 Global Airway Management Devices Market by Application
6.2.1 Market Overview
6.2.2 Anesthesia
6.2.3 Emergency Medicine
6.2.4 Others
6.3 Global Airway Management Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.2.1 Operating Rooms
6.3.2.2 Emergency Care Departments
6.3.2.3 Intensive Care Units
6.3.3 Ambulatory Care Settings
6.3.4 Home Care Settings
6.3.5 Others
6.4 Global Airway Management Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Airway Management Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Airway Management Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Airway Management Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Airway Management Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Airway Management Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic plc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Medline Industries, LP (Teleflex)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Ambu A/S
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Karl Storz SE & Co. KG
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Smiths Medical (Smiths Group Plc)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Koninklijke Philips N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Verathon
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Vyaire Medical, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Olympus Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 VBM Medizintechnik
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 TRACOE medical GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 SourceMark
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 SunMed
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Convatec Group
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthcare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Airway Management Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market size attained a value of USD 2.6 billion in 2022, driven by the rising cases of respiratory disorders.
The market is anticipated to grow at a CAGR of 6.20% during the forecast period of 2023-2031 to attain a value of USD 4.5 billion by 2031.
Airway management devices are the devices used for the management of airway obstruction. These devices consist of set procedures and operations used to prevent and treat airway obstruction.
The major factors propelling the growth of the market include the increasing prevalence of pulmonary disorders, novel product launches, and increased expenditure on research and development.
The device types in the market include infraglottic airway management devices, supraglottic airway management devices, laryngoscopes, and resuscitators, among others.
The product finds wide applications in anaesthesia and emergency medicine, among others.
The end-users for the device include hospitals, ambulatory care settings, and home care settings, among others.
The key companies in the market include Medtronic plc, Medline Industries, LP (Teleflex), Ambu A/S, Karl Storz SE & Co. KG, Smiths Medical (Smiths Group Plc), Koninklijke Philips N.V., Verathon, Vyaire Medical, Inc., Olympus Corporation, VBM Medizintechnik, TRACOE medical GmbH, SourceMark, SunMed, Convatec Group, and Siemens Healthcare.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.